RLYB / Rallybio Corporation - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Rallybio Corporation
US ˙ NasdaqCM ˙ US75120L1008

Deler fremragende 5,289,675 shares
Insideraktier2.991.268 shares
Insider ejerskab56,55 %
Total Insiders28
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-1 ( )
9270 out of 10963

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.025% ( )
9734 out of 10830

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Rallybio Corporation insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
5AM Opportunities I (GP), LLC 10% Owner - [10%] 1.406.098 309.871
5AM Opportunities I, L.P. 10% Owner - [10%] 2.478.969 309.871
5AM Partners V, LLC 10% Owner - [10%] 3.630.724 453.840
5AM Ventures V, L.P. 10% Owner - [10%] 1.406.098 453.840
Helen M Boudreau Director - [D] 23.882 2.985
FMR LLC / Fidelity Management & Research 10% Owner - [10%] 211.798 211.798
Jeffrey M Fryer See Remarks - [O] 47.048 5.881
Ole Andreas Halvorsen 10% Owner - [10%] 4.194.777 524.347
Ronald Hunt Director - [D] 2.301.603 287.700
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Robert Lorne Hopfner Director - [D] 2.267.411 283.426
Lucian Iancovici Director - [D] 0 0
Jonathan I Lieber Chief Financial Officer - [O] 4.115 4.115
Hui Liu 2.240
Martin Mackay Chief Executive Officer, Director - [D] [O] 282.609 35.326
Christine A Nash 2.240
Ott David C. 10% Owner - [10%] 4.194.777 524.347
Kush Parmar Director - [D] 3.630.724 453.840
Scott M Rocklage 10% Owner - [10%] 2.578.640 453.840
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Steven Ryder Chief Medical Officer - [O] 192.370 24.046
Timothy M Shannon Director - [D] 2.409.712 301.214
Schwab Andrew J. 10% Owner - [10%] 2.784.626 453.840
Rose Sharon Shabet 10% Owner - [10%] 4.194.777 524.347
Paula Soteropoulos Director - [D] 23.882 2.985
Stephen Uden See Remarks - [O] 719.127 89.891
Viking Global Investors Lp 10% Owner - [10%] 4.194.777 524.347
Viking Global Opportunities GP LLC 10% Owner - [10%] 4.194.777 524.347
Viking Global Opportunities Illiquid Investments Sub-Master LP 10% Owner - [10%] 4.194.777 524.347
Viking Global Opportunities Portfolio GP LLC 10% Owner - [10%] 4.194.777 524.347

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i RLYB / Rallybio Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-03-14 Lieber Jonathan I 5.000 5,2100 625 41,6800 26.050 84 8.8900 -20.494 -78,67
2022-03-21 Fryer Jeffrey M 3.000 8,0400 375 64,3200 24.120
2022-01-19 Fryer Jeffrey M 1.400 8,7000 175 69,6000 12.180
2022-01-13 Uden Stephen 4.193 9,0600 524 72,4800 37.989
2022-01-13 Uden Stephen 807 9,6200 101 76,9600 7.763
2022-01-12 Uden Stephen 5.000 10,5500 625 84,4000 52.750
2022-01-11 MACKAY MARTIN 4.496 10,6500 562 85,2000 47.882
2022-01-10 MACKAY MARTIN 5.504 10,1000 688 80,8000 55.590
2022-01-07 Fryer Jeffrey M 9.295 9,4400 1.162 75,5200 87.745

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RLYB / Rallybio Corporation Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i RLYB / Rallybio Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-02-23 Lieber Jonathan I 789 5,0600 789 5,0600 3.992 0 5.5000 348 8,70
2023-03-07 5AM Partners V, LLC 100.000 8,2000 12.500 65,6000 820.000
2022-06-03 5AM Opportunities I, L.P. 50.329 12,5000 6.291 100,0000 629.112
2022-06-03 5AM Opportunities I, L.P. 99.671 12,5000 12.459 100,0000 1.245.888
2022-05-23 5AM Opportunities I, L.P. 66.447 13,0000 8.306 104,0000 863.811
2022-05-23 5AM Opportunities I, L.P. 33.553 13,0000 4.194 104,0000 436.189
2022-02-08 5AM Opportunities I, L.P. 139.539 13,0500 17.442 104,4000 1.820.984
2022-02-08 5AM Opportunities I, L.P. 70.461 13,0500 8.808 104,4000 919.516

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RLYB / Rallybio Corporation Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-03-10 3 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP RLYB Common Stock I 211.798
2026-02-23 2026-02-23 4 Lieber Jonathan I RLYB Common Stock S - Sale D 5,0600 -789 -4 4.115
2026-02-23 2026-02-18 4 Lieber Jonathan I RLYB Common Stock A - Award D 2.500 4.904
2023-03-16 2023-03-14 4 Lieber Jonathan I RLYB Common Stock P - Purchase D 5,2100 5.000 26 5.000
2023-03-09 2023-03-07 4 PARMAR KUSH By 5AM Ventures V, L.P. RLYB Common Stock S - Sale I 8,2000 -100.000 -820 2.378.969
2023-03-09 2023-03-07 4 5AM Partners V, LLC By 5AM Ventures V, L.P. RLYB Common Stock S - Sale I 8,2000 -100.000 -820 2.378.969
2022-06-07 2022-06-03 4 PARMAR KUSH By 5AM Opportunities I, L.P. RLYB Common Stock S - Sale I 12,5000 -50.329 -629 1.251.755
2022-06-07 2022-06-03 4 PARMAR KUSH By 5AM Ventures V, L.P. RLYB Common Stock S - Sale I 12,5000 -99.671 -1.246 2.478.969
2022-06-07 2022-06-03 4 5AM Opportunities I, L.P. By 5AM Ventures V, L.P. RLYB Common Stock S - Sale I 12,5000 -99.671 -1.246 2.478.969
2022-06-07 2022-06-03 4 5AM Opportunities I, L.P. By 5AM Opportunities I, L.P. RLYB Common Stock S - Sale I 12,5000 -50.329 -629 1.251.755
2022-05-26 2022-05-24 4 Liu Hui RLYB Option (Right to Buy) A - Award D 12,75 2.240 2.240
2022-05-26 2022-05-24 4 HUNT RONALD RLYB Option (Right to Buy) A - Award D 12,75 13.440 13.440
2022-05-26 2022-05-24 4 Soteropoulos Paula RLYB Option (Right to Buy) A - Award D 12,75 13.440 13.440
2022-05-26 2022-05-24 4 Nash Christine A RLYB Option (Right to Buy) A - Award D 12,75 2.240 2.240
2022-05-26 2022-05-24 4 Hopfner Robert Lorne RLYB Option (Right to Buy) A - Award D 12,75 13.440 13.440
2022-05-26 2022-05-24 4 Boudreau Helen M RLYB Option (Right to Buy) A - Award D 12,75 13.440 13.440
2022-05-26 2022-05-24 4 PARMAR KUSH RLYB Option (Right to Buy) A - Award D 12,75 13.440 13.440
2022-05-25 2022-05-23 4 PARMAR KUSH By 5AM Opportunities I, L.P. RLYB Common Stock S - Sale I 13,0000 -33.553 -436 1.302.084
2022-05-25 2022-05-23 4 PARMAR KUSH By 5AM Ventures V, L.P. RLYB Common Stock S - Sale I 13,0000 -66.447 -864 2.578.640
2022-05-25 2022-05-23 4 5AM Opportunities I, L.P. By 5AM Ventures V, L.P. RLYB Common Stock S - Sale I 13,0000 -66.447 -864 2.578.640
2022-05-25 2022-05-23 4 5AM Opportunities I, L.P. By 5AM Opportunities I, L.P. RLYB Common Stock S - Sale I 13,0000 -33.553 -436 1.302.084
2022-04-06 2022-04-04 4 Nash Christine A RLYB Option (Right to Buy) A - Award D 8,22 26.880 26.880
2022-04-06 2022-04-04 4 Liu Hui RLYB Option (Right to Buy) A - Award D 8,22 26.880 26.880
2022-03-23 2022-03-21 4 Fryer Jeffrey M RLYB Common Stock P - Purchase I 8,0400 3.000 24 47.048
2022-02-10 2022-02-08 4 5AM Opportunities I, L.P. RLYB Common Stock S - Sale I 13,0500 -139.539 -1.821 2.645.087
2022-02-10 2022-02-08 4 5AM Opportunities I, L.P. RLYB Common Stock S - Sale I 13,0500 -70.461 -920 1.335.637
2022-02-10 2022-02-08 4 PARMAR KUSH 5AM Opportunities I, L.P. RLYB Common Stock S - Sale I 13,0500 -70.461 -920 1.335.637
2022-02-10 2022-02-08 4 PARMAR KUSH 5AM Ventures V, L.P. RLYB Common Stock S - Sale I 13,0500 -139.539 -1.821 2.645.087
2022-02-09 2022-02-07 4 Fryer Jeffrey M RLYB Option (Right to Buy) A - Award D 15,04 62.000 62.000
2022-02-09 2022-02-07 4 Uden Stephen RLYB Option (Right to Buy) A - Award D 15,04 62.000 62.000
2022-02-09 2022-02-07 4 MACKAY MARTIN RLYB Option (Right to Buy) A - Award D 15,04 62.000 62.000
2022-02-09 2022-02-07 4 Ryder Steven RLYB Option (Right to Buy) A - Award D 15,04 62.000 62.000
2022-01-21 2022-01-19 4 Fryer Jeffrey M RLYB Common Stock P - Purchase I 8,7000 1.400 12 44.048
2022-01-14 2022-01-13 4 Uden Stephen RLYB Common Stock P - Purchase D 9,6200 807 8 719.127
2022-01-14 2022-01-13 4 Uden Stephen RLYB Common Stock P - Purchase D 9,0600 4.193 38 718.320
2022-01-14 2022-01-12 4 Uden Stephen RLYB Common Stock P - Purchase D 10,5500 5.000 53 714.127
2022-01-14 2021-07-28 4 Uden Stephen RLYB Option (Right to Buy) A - Award D 13,00 160.000 160.000
2022-01-14 2021-07-28 4 Uden Stephen RLYB Series B Preferred Units J - Other D -107.891 0
2022-01-14 2021-07-28 4 Uden Stephen RLYB Series A-2 Preferred Units J - Other D -100.000 0
2022-01-14 2021-07-28 4 Uden Stephen RLYB Series A-1 Preferred Units J - Other D -150.000 0
2022-01-14 2021-07-28 4 Uden Stephen RLYB Common Units J - Other D -4.820.000 0
2022-01-14 2021-07-28 4 Uden Stephen RLYB Common Stock J - Other D 709.127 709.127
2022-01-12 2022-01-11 4 MACKAY MARTIN RLYB Common Stock P - Purchase D 10,6500 4.496 48 282.609
2022-01-12 2022-01-10 4 MACKAY MARTIN RLYB Common Stock P - Purchase D 10,1000 5.504 56 278.113
2022-01-12 2021-07-28 4 MACKAY MARTIN RLYB Option (Right to Buy) A - Award D 13,00 160.000 160.000
2022-01-12 2021-07-28 4 MACKAY MARTIN RLYB Series B Preferred Units J - Other I -107.891 0
2022-01-12 2021-07-28 4 MACKAY MARTIN RLYB Series A-2 Preferred Units J - Other I -100.000 0
2022-01-12 2021-07-28 4 MACKAY MARTIN RLYB Series A-1 Preferred Units J - Other I -150.000 0
2022-01-12 2021-07-28 4 MACKAY MARTIN RLYB Common Units J - Other I -2.564.999 0
2022-01-12 2021-07-28 4 MACKAY MARTIN RLYB Common Units J - Other D -2.255.001 0
2022-01-12 2021-07-28 4 MACKAY MARTIN RLYB Common Stock J - Other I 436.517 436.517
2022-01-12 2021-07-28 4 MACKAY MARTIN RLYB Common Stock J - Other D 272.609 272.609
2022-01-11 2022-01-07 4 Fryer Jeffrey M RLYB Common Stock P - Purchase I 9,4400 9.295 88 42.648
2022-01-11 2022-01-07 4 Fryer Jeffrey M RLYB Common Stock P - Purchase I 8,9700 705 6 33.353
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Option (Right to Buy) A - Award D 13,00 160.000 160.000
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Series B Preferred Units J - Other I -107.891 0
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Series A-2 Preferred Units J - Other I -100.000 0
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Series A-1 Preferred Units J - Other I -75.000 0
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Series A-1 Preferred Units J - Other I -75.000 0
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Common Units J - Other I -1.282.500 0
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Common Units J - Other I -1.282.500 0
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Common Units J - Other I -2.255.000 0
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Common Stock J - Other I 201.934 201.934
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Common Stock J - Other I 201.934 201.934
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Common Stock J - Other I 272.609 272.609
2022-01-11 2021-07-28 4 Fryer Jeffrey M RLYB Common Stock J - Other I 32.648 32.648
2022-01-05 2022-01-03 4 Hopfner Robert Lorne RLYB Option (Right to Buy) A - Award D 10,38 6.242 6.242
2022-01-05 2022-01-03 4 HUNT RONALD RLYB Option (Right to Buy) A - Award D 10,38 6.242 6.242
2022-01-05 2022-01-03 4 PARMAR KUSH RLYB Option (Right to Buy) A - Award D 10,38 5.772 5.772
2022-01-05 2022-01-03 4 Soteropoulos Paula RLYB Option (Right to Buy) A - Award D 10,38 5.369 5.369
2022-01-05 2022-01-03 4 SHANNON TIMOTHY M RLYB Option (Right to Buy) A - Award D 10,38 6.041 6.041
2021-08-04 2021-08-02 4 PARMAR KUSH 5AM Opportunities I, L.P. RLYB Common Stock P - Purchase I 13,0000 615.384 8.000 1.406.098
2021-08-04 2021-07-28 4 PARMAR KUSH RLYB Option (Right to Buy) A - Award D 13,00 13.440 13.440
2021-08-04 2021-07-28 4 PARMAR KUSH 5AM Opportunities I, L.P. RLYB Series B Preferred Units J - Other I -5.034.955 0
2021-08-04 2021-07-28 4 PARMAR KUSH 5AM Ventures V, LP. RLYB Series B Preferred Units J - Other I -7.192.795 0
2021-08-04 2021-07-28 4 PARMAR KUSH 5AM Ventures V, LP. RLYB Series A-2 Preferred Units J - Other I -8.742.654 0
2021-08-04 2021-07-28 4 PARMAR KUSH 5AM Ventures V, LP. RLYB Series A-1 Preferred Units J - Other I -1.795.946 0
2021-08-04 2021-07-28 4 PARMAR KUSH 5AM Opportunities I, L.P. RLYB Common Stock J - Other I 790.714 790.714
2021-08-04 2021-07-28 4 PARMAR KUSH 5AM Ventures V, L.P. RLYB Common Stock J - Other I 2.784.626 2.784.626
2021-08-04 3/A Schwab Andrew J. footnote RLYB Common Stock I 790.714
2021-08-04 3/A Schwab Andrew J. footnote RLYB Common Stock I 2.784.626
2021-08-04 2021-08-02 4 5AM Opportunities I, L.P. RLYB Common Stock P - Purchase I 13,0000 615.384 8.000 1.406.098
2021-08-04 2021-08-02 4 Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P RLYB Common Stock P - Purchase I 13,0000 576.923 7.500 2.267.411
2021-08-04 2021-07-28 4 Hopfner Robert Lorne RLYB Option (Right to Buy) A - Award D 13,00 13.440 13.440
2021-08-04 2021-07-28 4 Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P. RLYB Series B Preferred Units J - Other I -10.789.193 0
2021-08-04 2021-07-28 4 Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P RLYB Common Stock J - Other I 1.694.388 1.694.388
2021-08-04 2021-08-02 4 HUNT RONALD RLYB Common Stock P - Purchase I 13,0000 153.846 2.000 2.301.603
2021-08-04 2021-08-02 4 HUNT RONALD RLYB Common Stock P - Purchase I 13,0000 153.846 2.000 2.301.603
2021-08-04 2021-07-28 4 HUNT RONALD RLYB Option (Right to Buy) A - Award D 13,00 13.440 13.440
2021-08-04 2021-07-28 4 HUNT RONALD RLYB Series B Preferred Units J - Other I -2.157.838 0
2021-08-04 2021-07-28 4 HUNT RONALD RLYB Series A-2 Preferred Units J - Other I -8.742.654 0
2021-08-04 2021-07-28 4 HUNT RONALD RLYB Series A-1 Preferred Units J - Other I -1.795.946 0
2021-08-04 2021-07-28 4 HUNT RONALD RLYB Common Stock J - Other I 1.993.911 1.993.911
2021-08-04 2021-08-02 4 SHANNON TIMOTHY M Canaan XI L.P. RLYB Common Stock P - Purchase I 13,0000 76.923 1.000 2.409.712
2021-08-04 2021-07-28 4 SHANNON TIMOTHY M RLYB Option (Right to Buy) A - Award D 13,00 13.440 13.440
2021-08-04 2021-07-28 4 SHANNON TIMOTHY M Canaan XI L.P. RLYB Series B Preferred Units J - Other I -4.315.676 0
2021-08-04 2021-07-28 4 SHANNON TIMOTHY M Canaan XI L.P. RLYB Series A-2 Preferred Units J - Other I -8.742.654 0
2021-08-04 2021-07-28 4 SHANNON TIMOTHY M Canaan XI L.P. RLYB Series A-1 Preferred Units J - Other I -1.795.946 0
2021-08-04 2021-07-28 4 SHANNON TIMOTHY M Canaan XI L.P. RLYB Common Stock J - Other I 2.332.789 2.332.789
2021-08-04 2021-08-02 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP RLYB Series B Preferred Units C - Conversion I -10.789.193 0
2021-08-04 2021-08-02 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP RLYB Common Stock C - Conversion I 1.694.388 1.694.388
2021-08-02 2021-07-29 4 VIKING GLOBAL INVESTORS LP See Explanation of Responses RLYB Series B Preferred Units C - Conversion I -21.578.387 0
2021-08-02 2021-07-29 4 VIKING GLOBAL INVESTORS LP See Explanation Responses RLYB Common Stock P - Purchase I 13,0000 806.000 10.478 4.194.777
2021-08-02 2021-07-29 4 VIKING GLOBAL INVESTORS LP See Explanation Responses RLYB Common Stock C - Conversion I 3.388.777 3.388.777
2021-07-29 3 Schwab Andrew J. footnote RLYB Common Stock I 2.778.216
2021-07-29 3 Schwab Andrew J. footnote RLYB Common Stock I 788.894
2021-07-29 3 PARMAR KUSH RLYB Common Stock I 2.784.626
2021-07-29 3 PARMAR KUSH RLYB Common Stock I 790.714
2021-07-29 3 Iancovici Lucian RLYB No securities beneficially owned D 0
2021-07-29 3 Soteropoulos Paula RLYB Common Stock D 23.882
2021-07-29 3 Boudreau Helen M RLYB Common Stock D 23.882
2021-07-29 3 SHANNON TIMOTHY M Canaan XI L.P. RLYB Common Stock I 2.332.789
2021-07-29 3 Ryder Steven RLYB Common Stock D 192.370
2021-07-29 3 HUNT RONALD New Leaf Ventures III, L.P. RLYB Common Stock I 1.993.911
2021-07-29 3 Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P. RLYB Common Stock I 1.694.388
2021-07-29 3 MACKAY MARTIN RLYB Common Stock D 272.609
2021-07-29 3 MACKAY MARTIN RLYB Common Stock I 436.517
2021-07-29 3 Uden Stephen RLYB Common Stock D 709.127
2021-07-29 3 Fryer Jeffrey M RLYB Common Stock I 32.648
2021-07-29 3 Fryer Jeffrey M RLYB Common Stock I 201.934
2021-07-29 3 Fryer Jeffrey M RLYB Common Stock I 201.934
2021-07-29 3 Fryer Jeffrey M RLYB Common Stock I 272.609
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista